Literature DB >> 1542265

Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal.

S W Coppack1, R D Evans, R M Fisher, K N Frayn, G F Gibbons, S M Humphreys, M L Kirk, J L Potts, T D Hockaday.   

Abstract

Physiological actions of insulin include suppression of fat mobilization from adipose tissue and activation of adipose tissue lipoprotein lipase. Here, we report measurements of adipose tissue hormone-sensitive lipase (HSL) and lipoprotein lipase (LPL) action in vivo in 10 normal and eight obese subjects, with the latter group having varying degrees of glucose intolerance. HSL and LPL actions (per gram of adipose tissue) were similar in the two groups, after an overnight fast. In the normal subjects, HSL action was suppressed after a meal (by 75% +/- 6% between 60 to 300 minutes, P less than .01), and the action of LPL was increased (clearance of circulating triacylglycerol [TAG] increased by 140% +/- 57% at 300 minutes, P less than .05). Despite hyperinsulinemia, these responses were blunted in the obese subjects (P less than .05 for each change being less than in normal group). The adipose tissue of the obese subjects showed continued nonesterified fatty acid (NEFA) release at a time when NEFA mobilization was completely suppressed in the normal group. Both impaired suppression of HSL and low fractional retention of fatty acids for reesterification within the adipose tissue contributed to this abnormal NEFA release. Impaired activation of LPL was associated with a greater absolute increase in plasma TAG concentration postprandially in the obese. In obese subjects, adipose tissue HSL and LPL fail to respond to immunoreactive insulin postprandially, which may be an important maladaptation in terms of lipoprotein metabolism and risk of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542265     DOI: 10.1016/0026-0495(92)90269-g

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  42 in total

1.  Effects of insulin on adipose tissue blood flow in man.

Authors:  Fredrik Karpe; Barbara A Fielding; Jean-Luc Ardilouze; Vera Ilic; Ian A Macdonald; Keith N Frayn
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

Review 2.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

3.  Metabolic characteristics of human subcutaneous abdominal adipose tissue after overnight fast.

Authors:  Keith N Frayn; Sandy M Humphreys
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-13       Impact factor: 4.310

4.  Phenylalanine kinetics in human adipose tissue.

Authors:  S W Coppack; M Persson; J M Miles
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans.

Authors:  G H Goossens; S E McQuaid; A L Dennis; M A van Baak; E E Blaak; K N Frayn; W H M Saris; F Karpe
Journal:  J Physiol       Date:  2006-01-05       Impact factor: 5.182

6.  Pioglitazone increases non-esterified fatty acid clearance in upper body obesity.

Authors:  S Shadid; M D Jensen
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

Review 7.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids.

Authors:  C D Byrne; N J Wareham; D C Brown; P M Clark; L J Cox; N E Day; C R Palmer; T W Wang; D R Williams; C N Hales
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

9.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 10.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.